Ziopharm Oncology
ZIOP
#8774
Rank
S$0.24 B
Marketcap
S$1.12
Share price
-0.88%
Change (1 day)
-74.72%
Change (1 year)

Earnings for Ziopharm Oncology (ZIOP)

Earnings in 2021 (TTM): -S$0.12 Billion

According to Ziopharm Oncology's latest financial reports the company's current earnings are S$3.73 Million. In 2020 the company made an earning of -S$0.11 Billion a decrease over its 2019 earnings that were of -S$74.36 Million.

Earnings history for Ziopharm Oncology from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-S$0.12 Billion16.06%
2020-S$0.11 Billion38.89%
2019-S$74.36 Million7.33%
2018-S$69.28 Million0.77%
2017-S$68.75 Million-67.64%
2016-S$0.22 Billion37.64%
2015-S$0.16 Billion176.1%
2014-S$55.91 Million-24.63%
2013-S$74.18 Million-43.51%
2012-S$0.14 Billion43.09%
2011-S$91.76 Million190.88%
2010-S$31.55 Million102.46%
2009-S$15.59 Million-52.68%
2008-S$32.93 Million-10.33%
2007-S$36.72 Million15.35%
2006-S$31.84 Million355.36%
2005-S$7 Million13788.35%
2004-S$0.06 Million9.27%
2003-S$0.05 Million-10.26%
2002-S$0.06 Million-59.35%
2001-S$0.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
S$11.67 B-10,279.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-S$0.66 Billion 469.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.33 B-10,850.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
-S$3.54 Million-96.92%๐Ÿ‡บ๐Ÿ‡ธ USA